Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
Clinical trial NCT00076115 · COMPLETED
Trial details
- NCT number
- NCT00076115
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.